Navigating Practice Issues Related to the Unsatisfactory Cervicovaginal Papanicolaou Test: Survey Results of Laboratories Participating in the 2020 College of American Pathologists PAP Education Program.

IF 3.7 3区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Archives of pathology & laboratory medicine Pub Date : 2024-01-01 DOI:10.5858/arpa.2022-0330-CP
Abha Goyal, Christine N Booth, Rhona J Souers, Sana O Tabbara, Janie Roberson, Michael R Henry, Kaitlin E Sundling, Kelly Goodrich, Lananh Nguyen
{"title":"Navigating Practice Issues Related to the Unsatisfactory Cervicovaginal Papanicolaou Test: Survey Results of Laboratories Participating in the 2020 College of American Pathologists PAP Education Program.","authors":"Abha Goyal, Christine N Booth, Rhona J Souers, Sana O Tabbara, Janie Roberson, Michael R Henry, Kaitlin E Sundling, Kelly Goodrich, Lananh Nguyen","doi":"10.5858/arpa.2022-0330-CP","DOIUrl":null,"url":null,"abstract":"<p><strong>Context.—: </strong>Unsatisfactory Papanicolaou (Pap) tests pose a unique set of challenges to the laboratory with regard to their processing, review, reporting, and performance of human papillomavirus (HPV) testing. There are no standardized guidelines for the review process and handling of unsatisfactory Pap tests.</p><p><strong>Objective.—: </strong>To assess the current practice patterns regarding various aspects of the unsatisfactory Pap test, from processing to reporting, across laboratories worldwide.</p><p><strong>Design.—: </strong>A supplemental questionnaire was mailed to laboratories participating in the 2020 College of American Pathologists (CAP) Gynecologic Cytopathology (PAP Education) Program, requesting data regarding the unsatisfactory Pap test.</p><p><strong>Results.—: </strong>Of 1520 participating laboratories, 619 (40.7%) responded, and the responses of 577 laboratories were included for further analysis. Only 64.6% (373 of 577) laboratories used the unsatisfactory Pap test criteria as specified by the 2014 Bethesda System. About three-quarters of the respondents (433 of 576; 75.2%) routinely rescreened unsatisfactory Pap tests. Routine repreparation of such Pap tests was performed by 54.9% (316 of 576) of laboratories, and 52.0% (293 of 563) used glacial acetic acid for repreparing excessively bloody specimens. HPV test results were reported for unsatisfactory Pap tests, always or sometimes, by 62.4% (353 of 566) of respondents.</p><p><strong>Conclusions.—: </strong>This CAP survey reveals important information regarding the practice patterns pertaining to several aspects of the unsatisfactory Pap test. It also provides valuable insight into the quality assurance measures that can be implemented for such tests. Future studies can further aid in the standardization of all components of the handling of unsatisfactory Pap tests for overall quality improvement.</p>","PeriodicalId":8305,"journal":{"name":"Archives of pathology & laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.7000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of pathology & laboratory medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5858/arpa.2022-0330-CP","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Context.—: Unsatisfactory Papanicolaou (Pap) tests pose a unique set of challenges to the laboratory with regard to their processing, review, reporting, and performance of human papillomavirus (HPV) testing. There are no standardized guidelines for the review process and handling of unsatisfactory Pap tests.

Objective.—: To assess the current practice patterns regarding various aspects of the unsatisfactory Pap test, from processing to reporting, across laboratories worldwide.

Design.—: A supplemental questionnaire was mailed to laboratories participating in the 2020 College of American Pathologists (CAP) Gynecologic Cytopathology (PAP Education) Program, requesting data regarding the unsatisfactory Pap test.

Results.—: Of 1520 participating laboratories, 619 (40.7%) responded, and the responses of 577 laboratories were included for further analysis. Only 64.6% (373 of 577) laboratories used the unsatisfactory Pap test criteria as specified by the 2014 Bethesda System. About three-quarters of the respondents (433 of 576; 75.2%) routinely rescreened unsatisfactory Pap tests. Routine repreparation of such Pap tests was performed by 54.9% (316 of 576) of laboratories, and 52.0% (293 of 563) used glacial acetic acid for repreparing excessively bloody specimens. HPV test results were reported for unsatisfactory Pap tests, always or sometimes, by 62.4% (353 of 566) of respondents.

Conclusions.—: This CAP survey reveals important information regarding the practice patterns pertaining to several aspects of the unsatisfactory Pap test. It also provides valuable insight into the quality assurance measures that can be implemented for such tests. Future studies can further aid in the standardization of all components of the handling of unsatisfactory Pap tests for overall quality improvement.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
与宫颈阴道巴氏涂片不合格相关的实践问题导航:参加 2020 年美国病理学家学院 PAP 教育计划的实验室调查结果。
背景:不合格的巴氏涂片(Pap)在处理、审查、报告和人类乳头瘤病毒(HPV)检测方面给实验室带来了一系列独特的挑战。对于巴氏试验的审查过程和不合格巴氏试验的处理,目前还没有标准化的指导原则:目的:评估全球各实验室目前对不合格巴氏试验从处理到报告等各方面的实践模式:向参加 2020 年美国病理学家学会(CAP)妇科细胞病理学(PAP 教育)计划的实验室邮寄了一份补充问卷,要求提供有关不合格巴氏试验的数据:在 1520 家参与实验室中,有 619 家(40.7%)做出了回复,其中 577 家实验室的回复被纳入进一步分析。只有 64.6%(577 家实验室中的 373 家)的实验室使用了 2014 年贝塞斯达系统规定的不合格巴氏试验标准。约四分之三的受访者(576 个受访者中的 433 个;75.2%)对不合格的巴氏试验进行常规再筛查。54.9%的实验室(576 家中的 316 家)对此类巴氏试验进行了常规再制备,52.0%的实验室(563 家中的 293 家)使用冰醋酸对血样过多的标本进行再制备。62.4%的受访者(566 位受访者中的 353 位)总是或有时报告不满意的巴氏试验的 HPV 检测结果:这项 CAP 调查揭示了与不合格巴氏试验几个方面相关的实践模式的重要信息。它还为此类检测可采取的质量保证措施提供了有价值的见解。今后的研究可进一步帮助规范处理不合格子宫颈抹片检查的所有环节,以提高整体质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.20
自引率
2.20%
发文量
369
审稿时长
3-8 weeks
期刊介绍: Welcome to the website of the Archives of Pathology & Laboratory Medicine (APLM). This monthly, peer-reviewed journal of the College of American Pathologists offers global reach and highest measured readership among pathology journals. Published since 1926, ARCHIVES was voted in 2009 the only pathology journal among the top 100 most influential journals of the past 100 years by the BioMedical and Life Sciences Division of the Special Libraries Association. Online access to the full-text and PDF files of APLM articles is free.
期刊最新文献
Neoplastic Progression in Intraductal Papillary Neoplasm of the Bile Duct. Neoplastic Progression in Neuroendocrine Neoplasms of the Pancreas. Oncocytic Follicular Cell-Derived Thyroid Tumors With Papillary Growth Pattern: A Clinicopathologic Study of 32 Cases. Back-to-Back Comparison of Third-Generation Sequencing and Next-Generation Sequencing in Carrier Screening of Thalassemia. Hypertrophic Lichen Planus: An Up-to-Date Review and Differential Diagnosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1